Cimaher

Antineoplastic. Monoclonal antibody that joins the epidermic growth factor receptor. Indicated in head and neck cancer, esophagus cancer, pancreatic cancer, glioblastoma.

Therapeutic Area
Oncology

Active Ingredient
Nimotuzumab

Line
Oncology

Pharmaceutical Form
4 10ml ampoules with 50 mg of solution in a 5 mg/ml concentration

Download Leaflet Descargar